Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 440Rectal Neoplasms 209Colonic Neoplasms 201Pancreatic Neoplasms 131Stomach Neoplasms 116Neoplasm Metastasis 97Neoplasms 63Esophageal Neoplasms 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Lymphoma 49Leukemia 41Carcinoma, Hepatocellular 40Adenocarcinoma Of Esophagus 37Burkitt Lymphoma 33Adenocarcinoma 29Cholangiocarcinoma 26Biliary Tract Neoplasms 22Carcinoma, Non-Small-Cell Lung 21Gastrointestinal Neoplasms 20Lymphoma, Non-Hodgkin 19Gallbladder Neoplasms 19Esophageal Squamous Cell Carcinoma 15Osteosarcoma 14Bile Duct Neoplasms 14Unspecified Adult Solid Tumor, Protocol Specific 13Lymphoma, Large B-Cell, Diffuse 13Liver Neoplasms 13Leukemia, Biphenotypic, Acute 13Ovarian Neoplasms 12Leukemia, Myeloid, Acute 12

Interventions

Gemcitabine 5Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4selpercatinib 2niraparib 2napabucasin 2entinostat 2Ocoxin 2Irinotecan 2Bevacizumab 2temsirolimus 1tariquidar 1repotrectinib 1pralsetinib 1pembrolizumab 1irinotecan sucrosofate 1ganitumab 1Valproic Acid 1Trabectedin 1Taxes 1Sunitinib 1Sirolimus 1Psilocybin 1Paclitaxel 1Oxaliplatin 1Leucovorin 1Immunoglobulin G 1Fluorouracil 1Etoposide 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endocrine Gland Neoplasms × Leucovorin × Clear all
NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Sumitomo Pharma America, Inc.

Phase 1 Completed
139 enrolled
Gastrointestinal

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡